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Conclusions:
MLCT and DLG are not constant values for MLCs. They have directly related with depth and the number of CP. However many TPS allowed to user to insert only one value for each of them. The possibility of inserting more values for different parameters to TPS could be increase the accuracy level of dose calculation.
EP-1415
Calibration of diodes for in vivo dosimetry in breast treatments delivered using a sliding window IMRT technique A. Latorre Musoll 1 , P. Carrasco 1 , N. Jornet 1 , A. Ruiz 1 , T. Eudaldo 1 , M. Ribas 1 1 Hospital de la Santa Creu i Sant Pau, Servei de Radiofísica i Radioprotecció, Barcelona, Spain Purpose/Objective: Calibration of diodes for entrance dose in vivo dosimetry is a well-established method in conventional radiotherapy. However, the validity of such calibration is not straightforward when using sliding window IMRT techniques. We developed a calibration method of diodes for in vivo dosimetry in breast treatments delivered using a sliding window IMRT technique.
Materials and Methods:
We used a Clinac 2100C/D equipped with a Millenium 120 MLC (Varian). We calibrated 6-12 MV QED diodes (Sun Nuclear) by placing them on the surface of a Plastic Water phantom (CIRS), and comparing their readings to a traceable ionometric system placed at the depth of dose maximum for 6 MV x-rays (1.5 g/cm 2 ). Field size was set to 10 cm x 20 cm and SSD to 90 cm. The calibration geometry was set by averaging field size and SSD from 14 randomly-selected IMRT breast plans to minimize the value and uncertainty of field size and distance correction factors (CFs). Field size, distance and beam obliquity CFs were measured in two opposite scenarios: open and MLC-blocked fields. In between these scenarios, we obtained CFs using sliding window slits ranging from 2 to 25 mm to study their behaviour in sliding window IMRT conditions. We studied the influence of intra/interleaf leakage and beam hold-offs for gating techniques on diode readings. Results: Field size, distance and beam obliquity CFs were smooth functions of (X,Y), SSD and angle for open fields (table), and any interdependence between them was below 0.3%. For MLC-blocked fields, field size and distance CFs required a trilinear interpolation of a 3-dimensional matrix CF MLC (X,Y,SSD) (figures a-c). The obliquity CF was independent.
CFs for sliding window slits showed a smooth behaviour (as slit aperture increased) between MLC-blocked fields and open fields. Therefore, we defined an effective CF, CF eff , by combining the open and MLC-blocked fields CFs using a weighting factor 0 < τ < 1 which accounts for the fractional dose contribution of the MLC transmission:
Beam hold-offs did not affect diode readings. Diode placement with respect to the intra/interleaf assembly is random in nature, and the contribution of MLC transmission to dose is therefore variable. We found that intra/interleaf variations increased up to 55% for MLC-blocked fields as slit aperture decreased (figure d).
3rd ESTRO Forum 2015 S765 Conclusions: Calibration of diodes for in vivo dosimetry in breast treatments delivered using a sliding window IMRT technique requires non-linear CFs. Setting the calibration geometry close to the average irradiation geometry minimizes the value and uncertainty of CFs. We recommend two or more detectors per field, placed on high-fluence regions, to avoid false-positive warnings due to variations of MLC transmission. This work was funded by a grant from the Barcelona Board of the Spanish Association Against Cancer (AECC) 2012.
EP-1416 Classification of alerts observed during large scale in vivo portal dosimetry
A. Mans 1 , R.A. Rozendaal 1 , P. González 1 , M. Van Herk 1 , B.J.
Mijnheer 1 1 Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Radiation Oncology, Amsterdam, The Netherlands
Purpose/Objective: In our institution, almost all external beam radiotherapy treatments are verified using in vivo portal dosimetry, for reasons of efficiency and patient safety. Deviations between planned and EPID reconstructed dose occur mainly due to three causes: dose reconstruction model limitations, patient related causes and external factors. The aims of this work are: 1) to quantify the alert rate per treatment site, 2) to classify alerts according to the three abovementioned causes and 3) to prioritize improvement of our method. Materials and Methods: Portal images are converted to a 3D patient dose distribution by means of a simple backprojection model and the planning CT, and compared to the planned dose distribution by means of 3D gamma evaluation (default 3%, 3mm). Criteria are based on mean γ (γ mean ), 1% maximum γ (γ 1% ), percentage γ<1 (P γ<1 ) and dose difference at the dose reconstruction point (DRP) (ΔD DRP ). For IMRT/VMAT 3 different criteria levels are applied: (a) default: γ mean < 0.5, γ 1% < 2, P γ<1 > 85%, ΔD DRP < 3%, (b) breast: γ mean < 1.4, γ 1% < 5, P γ<1 > 50%, ΔD DRP < 3%, (c) GE and H&N: γ mean < 0.7, γ 1% < 2.5, P γ<1 > 80%, ΔD DRP < 4%. Non-IMRT treatments (mostly palliative) use (9%, 3mm) gamma parameters and γ mean < 0.9, ΔD DRP < 10% as alert criteria. The causes of deviation of all alerts from 2013 have been indicated by an experienced medial physicist. Alerts that resulted in clinical intervention were excluded (18 cases). The classification was done using information in the R&V system, anatomical information from CBCT, and the original comments when the alert was first reviewed clinically. Results: Table 1 shows the number of alerts per treatment site and assigned sources of deviation. 1397 out of 5766 verified plans were alerted (24%). Model limitations, patient related causes and external sources gave rise to false positive alerts in 1107 (19%), 557 (10%) and 101 cases (2%), respectively. In spite of less strict criteria, the alert rate in breast treatments is still 33%. This treatment site suffers from the absence of missing tissue compensation in our model and a well-known problem with transit dosimetry: setup errors (offline setup protocol). In addition, the use of bolus material in treatment planning is incompatible with portal dosimetry, contributing considerably to the alert rate. In all treatments, an unfavorable choice of the dose reference point location (e.g., on a high dose gradient) is an important cause of alerts. The impact of anatomy changes on portal dosimetry results is a topic of current research. Conclusions: 76% of in vivo portal dosimetry results is within criteria. Limitations of the back-projection model are the main source of alerts. In 10% of plans an alert is caused by patient setup and anatomy changes. This can be regarded as the baseline alert rate for in vivo portal dosimetry using the current criteria. Efforts to decrease the alert rate should focus on breast treatments, handling inhomogeneities and choice of dose reconstruction point.
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Is a decrease in dose rate in a kilovoltage X-ray radiotherapy unit directly linked to tube metallization? M. Lizondo 1 , A. Latorre-Mussol 1 , A. Ruiz 1 , N. Jornet 1 , T. Eudaldo 1 , P. Carrasco 1 , O. Jordi 1 , P. Delgado 1 , M. Ribas 1 1 Hospital de la Santa Creu i Sant Pau, Servei de Radiofísica i Radioprotecció, Barcelona, Spain Purpose/Objective: Kilovoltage x-ray radiotherapy units play an important role in skin cancer treatment. Over the last ten years, our QA programme has shown a decrease in dose rate in our Therapax SXT 150 (Pantak Seifert) unit. We studied whether tube metallization could explain this variation in dose rate by comparing our QA records with simulated data. Materials and Methods: The Therapax SXT 150 has a metalceramic x-ray tube (MXR-161) and provides 8 beam qualities ranging from 50kV, 0.45 mm Al HVL (lowest beam quality) to 150 kV, 1.48 mm Cu HVL. A set of applicators defines circular field sizes with diameters ranging from 1 to 15 cm. The QA programme for this unit, based on IAEA TECDOC-1151 (and TRS-398 for absorbed dose D w determination), quarterly assesses the constancy of: D w rate, HVL, quality index QI (defined as the ratio of absorbed doses at two fixed depths), output factors, field size, symmetry, homogeneity, timer
